Denmark's Fluimedix Raises $1.1M to Develop Warfarin Test for PCR-Based Platform

Fluimedix is developing a diagnostic test for warfarin metabolism on the NanoCycler, its benchtop, PCR-based diagnostic platform.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories